KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,667,222 | +313.5% | 27,602 | +430.3% | 0.01% | +366.7% |
Q2 2023 | $1,128,704 | -60.9% | 5,205 | -64.6% | 0.00% | -70.0% |
Q4 2022 | $2,888,747 | -77.8% | 14,701 | -74.5% | 0.01% | -83.3% |
Q3 2022 | $12,988,000 | +1339.9% | 57,744 | +683.3% | 0.06% | +1900.0% |
Q3 2021 | $902,000 | -55.3% | 7,372 | -58.4% | 0.00% | -57.1% |
Q2 2021 | $2,020,000 | -47.0% | 17,717 | -44.1% | 0.01% | -58.8% |
Q1 2021 | $3,811,000 | -26.8% | 31,698 | -38.2% | 0.02% | -26.1% |
Q4 2020 | $5,209,000 | +39.9% | 51,273 | +6.4% | 0.02% | +53.3% |
Q3 2020 | $3,724,000 | -7.3% | 48,168 | +33.6% | 0.02% | -25.0% |
Q2 2020 | $4,018,000 | – | 36,048 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |